Remove Clinical Trials Remove Doctors Remove Pharma Companies
article thumbnail

Using technology to reassess the clinical trial landscape

pharmaphorum

Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinical trial process by using data, helping to cut costs and allowing for evaluation of broader patient populations. .

article thumbnail

Communicating with HCPs via email

World of DTC Marketing

SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharma companies, according to Indegene. Also, one message to ALL doctors sold not make sense. They especially like data about clinical trial updates.

Doctors 180
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Your HCP marketing just became harder, a lot harder

World of DTC Marketing

doctors surveyed in the same time period, 77% said their trust in the CDC has decreased and 48% said their trust in the FDA has decreased. According to Medscape, “doctors and nurses reported relatively lower trust in the CDC than WebMD readers. Out of nearly 450 U.S.

Marketing 187
article thumbnail

Edelman Trust Barometer raises questions

World of DTC Marketing

But do doctors trust the system? consumers’ trust in pharma is low, despite the industry’s contributions to ending the pandemic: Only 15% of U.S. consumers say they trust pharma companies more than they did before the COVID-19 pandemic, according to Accenture’s 2021 survey.

article thumbnail

Tapping into digital therapeutics to improve neurological outcomes

Pharmaceutical Technology

This is partly due to the differing business models used by pharma companies and digital therapeutic developers. According to Anguera, the field is in its infancy, particularly when it comes to testing approaches in clinical trials. Securing reimbursement for digital therapeutics also continues to impede its uptake.

article thumbnail

Katie Porter attacks pharma

World of DTC Marketing

The venture capitalists funding them are looking for a big payday when a pharma company acquires them. I have been recruited by these companies who promise huge payouts when they are acquired if their drug shows promise in clinical trials. In pharma R&D returns have declined to 1.8 percent from 2018.

In-Vivo 187
article thumbnail

3 Barriers Between Patients and Clinical Research

Find Me Cure

As part of our patient advocacy efforts, at FindMeCure we are dedicated to creating a bridge between patients and the world of clinical research. This includes spreading clinical trial awareness, connecting patients to the trials they are interested in but also speaking up about the issues in the clinical research industry. .